NCT06417892 2025-01-14
Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
The First Hospital of Jilin University
Tianjin Medical University Cancer Institute and Hospital